Cullinan Therapeutics, Inc. (CGEM) — 8-K Filings

8-K Filings (15)

• 8-K Filing — May 7, 2026
• Cullinan Therapeutics Files 8-K — Dec 8, 2025 Risk: low
  Cullinan Therapeutics, Inc. filed an 8-K on December 8, 2025, reporting on other events and financial statements. The company, formerly known as Cullinan Oncolo
• 8-K Filing — Nov 21, 2025
• Cullinan Therapeutics Files 8-K — Nov 3, 2025 Risk: low
  Cullinan Therapeutics, Inc. filed an 8-K on November 3, 2025, reporting on various events. The filing includes information related to Regulation FD Disclosure,
• Cullinan Therapeutics Files 8-K — Sep 4, 2025 Risk: low
  Cullinan Therapeutics, Inc. filed an 8-K on September 04, 2025, reporting its status as a registrant. The company's common stock trades under the symbol CGEM on
• Cullinan Therapeutics Files 8-K on Security Holder Votes — Jun 12, 2025 Risk: low
  Cullinan Therapeutics, Inc. filed an 8-K on June 12, 2025, to report on matters submitted to a vote of its security holders. The filing indicates a change in th
• Cullinan Therapeutics Files 8-K for Material Agreement — Jun 4, 2025 Risk: medium
  Cullinan Therapeutics, Inc. filed an 8-K on June 4, 2025, reporting the entry into a material definitive agreement. The filing also includes Regulation FD discl
• Cullinan Therapeutics Files 8-K — Jan 29, 2025 Risk: low
  Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) filed an 8-K on January 29, 2025, reporting events as of January 28, 2025. The filing includes in
• Cullinan Therapeutics Files 8-K — Oct 16, 2024 Risk: low
  Cullinan Therapeutics, Inc. filed an 8-K on October 16, 2024, reporting on other events and financial statements. The company, formerly known as Cullinan Oncolo
• Cullinan Therapeutics Files 8-K — Sep 17, 2024 Risk: low
  Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) filed an 8-K on September 17, 2024, reporting on events including a Regulation FD Disclosure and
• Cullinan Therapeutics Files 8-K on Shareholder Vote Matters — Jun 27, 2024 Risk: low
  Cullinan Therapeutics, Inc. filed an 8-K on June 27, 2024, reporting on a submission of matters to a vote of security holders that occurred on June 26, 2024. Th
• Cullinan Therapeutics (CGEM) Files 8-K — Jun 3, 2024 Risk: low
  Cullinan Therapeutics, Inc. (CGEM) filed an 8-K on June 01, 2024, reporting its principal executive offices at One Main Street, Suite 1350, Cambridge, Massachus
• Cullinan Therapeutics Files 8-K — May 23, 2024 Risk: low
  Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) filed an 8-K on May 23, 2024, reporting on other events and financial statements. The company, in
• Cullinan Therapeutics Appoints New CFO — Apr 29, 2024 Risk: low
  Cullinan Therapeutics, Inc. announced on April 29, 2024, the appointment of Patrick J. O'Brien as Chief Financial Officer, effective immediately. O'Brien previo
• Cullinan Therapeutics Files 8-K — Apr 16, 2024 Risk: low
  Cullinan Therapeutics, Inc. (formerly Cullinan Oncology, Inc.) filed an 8-K on April 15, 2024, to report its current status. The filing confirms its principal e

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX